Clinical · Molecular biology
Circulating Tumor High Risk HPV DNA as the HPV-Specific Test in Oropharyngeal Squamous Cell Carcinoma Patients
Summary
This study investigated the concordance of circulating tumor human papillomavirus DNA (ctHPVDNA) with tissue-based HPV testing for diagnosing HPV-associated oropharyngeal squamous cell carcinoma (HPV+OPSCC). Researchers analyzed 236 patients, comparing ctHPVDNA (NavDx assay) results with p16 immunohistochemistry and ISH. ctHPVDNA demonstrated 100% specificity and positive predictive value, suggesting a positive result is highly reliable. However, its sensitivity of 85% and negative predictive value of 17% indicate that a negative result still necessitates confirmation with tissue-based tests.
Critical appraisal
This research is crucial for optimizing the diagnostic pathway for patients with oropharyngeal squamous cell carcinoma. The high specificity and positive predictive value of ctHPVDNA could potentially streamline diagnosis by avoiding additional invasive biopsies or tissue tests in cases of a positive result and high clinical suspicion. This could accelerate patient management and reduce the burden on patients and laboratories. Nevertheless, the necessity to confirm negative results underscores the importance of not entirely abandoning traditional tissue-based methods.
The summary and the appraisal were written by a language model from the title and abstract of the original article. The article was selected automatically by a model, without human review. Methodology